ClinicalTrials.gg
CompletedNCT07921628WARM-SHOTUpdated Nov 6, 2026

Effect of ShotBlocker and Warm Gel Pack on Heel Stick Pain in Newborns

An interventional study of ShotBlocker and Warm Gel Pack in Neonatal Pain and Procedural Pain, sponsored by Istinye University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 1 Day to 28 Days, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Istinye University · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Sep 2025, registered Jun 2026).
Updated Nov 6, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
147
Allocation
Randomized
Ages
1 Day to 28 Days
Sex
All
01

Study summary

Newborns routinely undergo heel stick procedures for blood screening tests shortly after birth. Although the procedure is brief, it can cause pain, stress, and physiological changes. Effective pain management is important because early painful experiences may affect newborn well-being and development.

Nonpharmacological methods are commonly used to reduce procedural pain in newborns because they are safe, easy to apply, and inexpensive. Two such methods are the ShotBlocker device, which provides tactile stimulation to reduce pain perception, and warm gel packs, which increase local blood flow and may improve comfort during the procedure. However, evidence regarding their effectiveness during heel stick procedures remains limited. This randomized controlled trial was conducted to compare the effects of ShotBlocker and warm gel pack applications during heel stick procedures in healthy term newborns. A total of 147 newborns were randomly assigned to a ShotBlocker group, a warm gel pack group, or a control group receiving routine care. The study evaluated procedural pain using the Neonatal Infant Pain Scale (NIPS), comfort using the Neonatal Comfort Behavior Scale, and physiological responses including heart rate, respiratory rate, oxygen saturation, and heel temperature. The findings may help identify practical, noninvasive approaches to improve pain management and comfort during routine newborn procedures.

Read the detailed description

Heel stick blood sampling is one of the most frequently performed painful procedures in newborn care. Although the procedure is brief, it may trigger behavioral and physiological pain responses. Effective management of procedural pain is an important component of neonatal care because early painful experiences may influence short- and long-term outcomes. Nonpharmacological interventions are widely recommended for the management of procedural pain in newborns because they are safe, inexpensive, and easy to implement in clinical settings. ShotBlocker is a device designed to reduce pain perception through tactile stimulation based on the gate control theory of pain. Warm gel packs may promote local vasodilation, increase peripheral circulation, and potentially reduce discomfort during heel stick procedures. However, evidence comparing these interventions during heel stick blood sampling is limited. This study was designed as a three-arm randomized controlled trial to evaluate the effects of ShotBlocker and warm gel pack applications on pain, comfort, and physiological responses during heel stick procedures in healthy term newborns. Participants were randomly assigned to a ShotBlocker group, a warm gel pack group, or a control group receiving routine care. Pain was assessed using the Neonatal Infant Pain Scale (NIPS), and comfort was assessed using the Neonatal Comfort Behavior Scale. Physiological parameters, including heart rate, respiratory rate, oxygen saturation, and heel temperature, were measured before and after the procedure. The results of this study may contribute to the evidence base regarding practical nonpharmacological strategies for procedural pain management in newborns.

02

Conditions studied

  • Neonatal Pain
  • Procedural Pain

Browse trials for

Keywords

  • Neonatal Pain
  • Procedural Pain
  • Heel Stick
  • Newborn
  • Pain Management
  • ShotBlocker
  • Warm Gel Pack
  • Comfort
  • Physiological Parameters
  • Randomized Controlled Trial
03

In context

Pain, Procedural

241 studies on the registry are indexed under Pain, Procedural; 64 are open to participants now.

This study's enrollment of 147 is above the median of 90 across 227 interventional studies indexed under Pain, Procedural.

Browse Pain, Procedural studies →

Lead sponsor

Istinye University is the lead sponsor of 221 studies on the registry; 94 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Day to 28 Days
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Healthy term newborns (37-42 weeks of gestation)
  • Undergoing routine heel stick blood sampling
  • Clinically stable at the time of the procedure
  • Parental written obtained

Exclusion criteria

Exclusion Criteria:

  • Preterm or post-term newborns
  • Presence of congenital anomalies
  • Neurological disorders or conditions affecting pain responses
  • Receipt of analgesic or sedative medication before the procedure
  • Any medical condition requiring intensive care or causing clinical instability
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
147 participants (actual)

Study arms

  • Experimental
    ShotBlocker Group

    Healthy term newborns in this group received the ShotBlocker device during the heel stick procedure. The device was applied around the puncture site according to the study protocol to provide tactile stimulation during the procedure.

    Device: ShotBlocker

  • Experimental
    Warm Gel Pack Group

    Healthy term newborns in this group received a warm gel pack application before the heel stick procedure according to the study protocol.

    Other: Warm Gel Pack

  • No intervention
    Control Group

    Healthy term newborns in this group received routine heel stick care without ShotBlocker or warm gel pack application.

Interventions

  • DeviceShotBlocker

    The ShotBlocker device was applied around the heel puncture site during the heel stick procedure according to the study protocol. The device provides multiple points of tactile stimulation intended to reduce pain perception during the procedure.

  • OtherWarm Gel Pack

    A warm gel pack was applied to the heel before the heel stick procedure according to the study protocol. The intervention was intended to increase local warmth and circulation during blood sample collection.

06

What researchers measure

Primary outcomes

  1. Neonatal Infant Pain Scale (NIPS) Score After Heel Stick Procedure

    Pain response measured using the Neonatal Infant Pain Scale (NIPS) immediately after the heel stick procedure. Higher scores indicate greater pain response.

    Time frame: Immediately after the heel stick procedure

Secondary outcomes

  1. Neonatal Comfort Behavior Scale (NCBS) Score

    Comfort level measured using the Neonatal Comfort Behavior Scale before and after the heel stick procedure.

    Time frame: Before and immediately after the heel stick procedure

  2. Heart Rate Change

    Difference between pre-procedure and post-procedure heart rate measurements.

    Time frame: Immediately before and immediately after the heel stick procedure

  3. Respiratory Rate Change

    Difference between pre-procedure and post-procedure respiratory rate measurements.

    Time frame: Immediately before and immediately after the heel stick procedure

  4. Oxygen Saturation Change

    Difference between pre-procedure and post-procedure oxygen saturation measurements.

    Time frame: Immediately before and immediately after the heel stick procedure

  5. Heel Temperature Change

    Difference between pre-procedure and post-procedure heel temperature measurements.

    Time frame: Immediately before and immediately after the heel stick procedure

07

Study locations

1 site
  • Marmara University
    Istanbul, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Registered
First appeared on the registry. No changes since
Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07921628
Lead sponsor
Istinye University
Responsible party
Ayşegül Şimşek, PhD (Assoc. Prof. Dr., Istinye University) — Principal investigator
First posted
Nov 6, 2026
Start date
Sep 1, 2025
Primary completion
May 1, 2026
Completion
May 30, 2026
Last update
Nov 6, 2026

Study contacts

Aysegu Simsek, Ph.D.
principal investigator · Marmara University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion